Inrenal cancer, ZEB2 has been shown to be a target of miR-205, whichis described as a tumor suppressor. Additionally,in ovarian cancer cells, ZEB2 has been identified as a target of miR-205. Here, ZEB2 is linked to ovarian carcinoma.